Medincell SA Cash Flow-to-Debt Ratio
Medincell SA cash flow-to-debt ratio. Medincell SA (MEDCL) has a Cash Flow-to-Debt Ratio of -0.10x as of March 2026, meaning its operating cash flow of €-10.84 Million could theoretically repay 0% of its total liabilities (€104.99 Million) in one year. Check MEDCL total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Medincell SA (2016–2026)
Cash flow-to-debt ratio of Medincell SA from 2016 to 2026. Historical debt coverage capacity for Medincell SA across 11 annual periods. Check Medincell SA cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Medincell SA Cash Flow-to-Debt Ratio by Year (2016–2026)
Medincell SA cash flow-to-debt ratio by year from 2016 to 2026. Year-by-year debt coverage analysis for Medincell SA. For the full cash flow conversion analysis, see Medincell SA cash conversion from operations.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2026 | -0.23x | €-24.55 Million | €104.99 Million | ▼ -228.3% |
| 2025 | 0.18x | €19.46 Million | €106.82 Million | ▲ +218.9% |
| 2024 | -0.15x | €-11.92 Million | €77.77 Million | ▲ +47.7% |
| 2023 | -0.29x | €-21.00 Million | €71.63 Million | ▲ +20.8% |
| 2022 | -0.37x | €-21.36 Million | €57.67 Million | ▼ -66.9% |
| 2021 | -0.22x | €-12.14 Million | €54.69 Million | ▲ +23.4% |
| 2020 | -0.29x | €-12.54 Million | €43.27 Million | ▲ +42.3% |
| 2019 | -0.50x | €-15.93 Million | €31.74 Million | ▼ -243.2% |
| 2018 | -0.15x | €-5.43 Million | €37.10 Million | ▼ -10.1% |
| 2017 | -0.13x | €-3.39 Million | €25.55 Million | ▼ -2023.0% |
| 2016 | 0.01x | €68.00K | €9.85 Million | — |